title: Invited commentary.
authors: Division of Cardiac Surgery, University of Ottawa Heart Institute, 40 Ruskin St, Rm H3404B, Ottawa, ONK1Y 4W7, Canada. phendry@ottawaheart.ca
authors: Paul
authors: P
authors: Hendry
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000601:surgery; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D017115:Catheter Ablation; D003131:Combined Modality Therapy; D006801:Humans; D000077405:Irbesartan; D019060:Minimally Invasive Surgical Procedures; D013777:Tetrazoles / Q000627:therapeutic use*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D001713:Biphenyl Compounds; D013777:Tetrazoles; D000077405:Irbesartan